QUALITATIVE interviews found trust and clear roles shape vaccination decisions in inflammatory rheumatologic disease care settings.
Vaccination Decisions in iRMD Patients Reflect Communication and Care Pathways
A qualitative interview study from Germany explored factors influencing vaccination decisions among people with inflammatory rheumatic and musculoskeletal diseases (iRMD), alongside perspectives from general practitioners and rheumatologists. Researchers interviewed 15 iRMD patients, 10 general practitioners, and five rheumatologists using semi structured formats, then analyzed responses with a structured qualitative content approach focused on attitudes, information needs, decision making, and perceived role distribution in care.
Trust, Consistent Information, and Clear Responsibilities Supported Uptake
Across participant groups, a trust-based doctor patient relationship and information that was consistent and easy to understand were described as central facilitators for vaccination decisions. Patients reported that clear explanations and alignment between clinicians increased confidence in vaccination and reduced uncertainty during decision making. Participants also highlighted the value of predictable pathways, including knowing who initiates vaccination discussions and how follow through is coordinated.
Uncertainty About Immunosuppressants and Conflicting Recommendations Created Barriers
Interviewees described several recurring barriers that complicated vaccination decisions. Patients raised uncertainties about how immunosuppressants might affect vaccination, and reported that inconsistent or conflicting medical recommendations undermined confidence. Another theme was ambiguity about responsibility between general practitioners and rheumatologists, with patients expressing a preference for a proactive approach from physicians and clearly assigned roles. Clinicians emphasized the need for interprofessional exchange, while also noting time constraints and structural challenges that made coordination difficult.
In their conclusion, the authors framed these findings as support for more coordinated communication and clearer task allocation in vaccination processes for iRMD care. The study was registered in the German Register of Clinical Studies (DRKS00031559).
Reference: Suslow A. Factors influencing vaccination decisions in patients with inflammatory rheumatic and musculoskeletal disease: a qualitative approach. BMC Rheumatol. 2026; doi: 10.1186/s41927-025-00608-6.
